Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"

被引:221
作者
Filippi, M
Rovaris, M
Rocca, MA
Sormani, MP
Wolinsky, JS
Comi, G
机构
[1] Sci Inst Milan, Dept Neurosci, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Sci Inst Milan, Dept Neurosci, Clin Trials Unit, I-20132 Milan, Italy
[3] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy
[4] Natl Inst Canc Res, Unit Clin Epidemiol & Trials, Genoa, Italy
[5] Univ Texas, Hlth Sci Ctr, Houston, TX USA
关键词
D O I
10.1212/WNL.57.4.731
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors evaluated whether glatiramer acetate (GA) modifies the severity of tissue damage in 1,722 new lesions from 239 patients with MS enrolled in a placebo-controlled trial monitored with monthly cerebral MRI. The percentage of new lesions that evolved into "black holes" was lower in GA-treated than in placebo patients on scans at 7 (18.9 and 26.3%; p = 0.04) and 8 (15.6 and 31.4%; p = 0.002) months after lesion appearance. GA has a favorable effect on tissue disruption in MS lesions once they are formed.
引用
收藏
页码:731 / 733
页数:3
相关论文
共 11 条
[1]   Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1 [J].
Aharoni, R ;
Teitelbaum, D ;
Sela, M ;
Arnon, R .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 91 (1-2) :135-146
[2]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[3]   Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis [J].
Ciccarelli, O ;
Giugni, E ;
Paolillo, A ;
Mainero, C ;
Gasperini, C ;
Bastianello, S ;
Pozzilli, C .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) :455-459
[4]   European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis [J].
Comi, G ;
Filippi, M ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 49 (03) :290-297
[5]   COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
JOHNSON, KP ;
BROOKS, BR ;
COHEN, JA ;
FORD, CC ;
GOLDSTEIN, J ;
LISAK, RP ;
MYERS, LW ;
PANITCH, HS ;
ROSE, JW ;
SCHIFFER, RB ;
VOLLMER, T ;
WEINER, LP ;
WOLINSKY, JS ;
BIRD, SJ ;
CONSTANTINESCU, C ;
KOLSON, DL ;
GONZALEZSCARANO, F ;
BRENNAN, D ;
PFOHL, D ;
MANDLER, RN ;
ROSENBERG, GA ;
JEFFREY, C ;
BARGER, GR ;
GANDHI, B ;
MOORE, PM ;
ROGERS, LR ;
LISAK, D ;
SMITH, L ;
ELLISON, GW ;
BAUMHEFNER, RW ;
CRAIG, SL ;
JALBUT, SS ;
KATZ, E ;
CONWAY, KL ;
BURNS, JB ;
SHIBA, C ;
GIANG, DW ;
PETRIE, MD ;
GUARNACCIA, JB ;
ANDERSON, S ;
MCKEON, A ;
MCCARTHY, M ;
THOMAS, AB ;
VRIESENDORP, FJ ;
AUSTIN, SG ;
LINDSEY, JW ;
DIMACHKIE, M ;
CERRETA, E ;
KACHUCK, N ;
MCCARTHY, KA .
NEUROLOGY, 1995, 45 (07) :1268-1276
[6]  
Rovira A, 1999, AM J NEURORADIOL, V20, P1939
[7]   Axonal transection in the lesions of multiple sclerosis [J].
Trapp, BD ;
Peterson, J ;
Ransohoff, RM ;
Rudick, R ;
Mörk, S ;
Bö, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :278-285
[8]  
van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675
[9]  
van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.0.CO
[10]  
2-9